3.4. Glucose Metabolism
During the intervention, HbA1c changed by −0.1% (IQR −0.3% to 0.1%) and −0.2% (IQR −0.4% to 0%) in the LCD and VLCD groups, respectively. Fasting plasma glucose changed by −6 (IQR −22 to 0) mg/dL and −7 (IQR −11 to 1) mg/dL in the LCD and VLCD groups, respectively. The within-group changes in ΔHbA1c and Δfasting plasma glucose were statistically significant. There was no significant difference in these parameters in the between-group comparison (